Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    - Revision updated from v3.5.4 to v3.5.5, indicating a small metadata update to the page.
    Difference
    0.0%
    Check dated 2026-06-09T14:56:29.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    New update dates were added (2026-05-21 and 2026-05-22) and older dates (2026-05-12, 2026-05-13, and 2025-11) were removed from the Study Record Dates, reflecting recent administrative updates to the page.
    Difference
    0.1%
    Check dated 2026-05-26T11:58:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A new Sample Collection section was added to the study plan, and the record was updated to revision v3.5.4, signaling changes in how specimens are collected and documented for the trial.
    Difference
    0.2%
    Check dated 2026-05-19T05:23:10.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page footer revision identifier was updated from v3.5.2 to v3.5.3, reflecting a site versioning change rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-27T11:51:48.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-20T05:57:08.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:15:35.000Z thumbnail image

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.